NO20020252D0 - Thixocortol pivalate suspension, mouthwash based thereon and packages containing the same - Google Patents

Thixocortol pivalate suspension, mouthwash based thereon and packages containing the same

Info

Publication number
NO20020252D0
NO20020252D0 NO20020252A NO20020252A NO20020252D0 NO 20020252 D0 NO20020252 D0 NO 20020252D0 NO 20020252 A NO20020252 A NO 20020252A NO 20020252 A NO20020252 A NO 20020252A NO 20020252 D0 NO20020252 D0 NO 20020252D0
Authority
NO
Norway
Prior art keywords
same
suspension
packages containing
thixocortol pivalate
mouthwash
Prior art date
Application number
NO20020252A
Other languages
Norwegian (no)
Other versions
NO20020252L (en
Inventor
Bernard Doat
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20020252D0 publication Critical patent/NO20020252D0/en
Publication of NO20020252L publication Critical patent/NO20020252L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Cartons (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Supplying Of Containers To The Packaging Station (AREA)
  • Wrapping Of Specific Fragile Articles (AREA)
  • Vehicle Body Suspensions (AREA)
  • Polymerisation Methods In General (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention concerns a micronized aqueous suspension of toxicortol pivalate, in a solution containing a surfactant and a viscosity agent. The invention also concerns a mouth-wash based on said suspension. The invention is useful for treating inflammations in the laryngeal, bucco-pharyngeal and rhino-pharyngeal zones.
NO20020252A 1999-07-22 2002-01-17 Thixocortol pivalate suspension, mouthwash based thereon and packages containing the same NO20020252L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9909556A FR2796553B1 (en) 1999-07-22 1999-07-22 SUSPENSION OF TIXOCORTOL PIVALATE, COLLUTORY BASED ON SAME AND PACKAGING CONTAINING SAME
PCT/FR2000/001987 WO2001007053A1 (en) 1999-07-22 2000-07-07 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same

Publications (2)

Publication Number Publication Date
NO20020252D0 true NO20020252D0 (en) 2002-01-17
NO20020252L NO20020252L (en) 2002-01-17

Family

ID=9548429

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020252A NO20020252L (en) 1999-07-22 2002-01-17 Thixocortol pivalate suspension, mouthwash based thereon and packages containing the same

Country Status (25)

Country Link
EP (1) EP1200096B1 (en)
JP (1) JP2003505421A (en)
KR (1) KR100718211B1 (en)
AT (1) ATE269088T1 (en)
AU (1) AU6296700A (en)
BG (1) BG106358A (en)
BR (1) BR0012671A (en)
CA (1) CA2378390C (en)
CZ (1) CZ2002144A3 (en)
DE (1) DE60011620T2 (en)
DK (1) DK1200096T3 (en)
DZ (1) DZ3207A1 (en)
EE (1) EE200200039A (en)
ES (1) ES2219366T3 (en)
FR (1) FR2796553B1 (en)
HK (1) HK1046850B (en)
HU (1) HUP0202055A3 (en)
IS (1) IS6228A (en)
MX (1) MXPA02000834A (en)
NO (1) NO20020252L (en)
OA (1) OA11993A (en)
PL (1) PL354100A1 (en)
PT (1) PT1200096E (en)
SK (1) SK762002A3 (en)
WO (1) WO2001007053A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5461785B2 (en) * 2008-03-31 2014-04-02 小林製薬株式会社 Pharmaceutical composition for repeated infection prevention
JP5317512B2 (en) * 2008-03-31 2013-10-16 小林製薬株式会社 Moisturizing composition
JP2013123450A (en) * 2011-12-13 2013-06-24 Akihiro Sato Medical treatment method of pneumoconiosis to which metal complex ion liquid is applied, and medical treatment method of pharynx, trachea and bronchus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877781A (en) * 1987-09-30 1989-10-31 Peter G. LaHaye Medical dispenser and preparation for inflamed tissue
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance

Also Published As

Publication number Publication date
DE60011620D1 (en) 2004-07-22
EP1200096B1 (en) 2004-06-16
ATE269088T1 (en) 2004-07-15
CZ2002144A3 (en) 2002-06-12
DE60011620T2 (en) 2005-07-21
IS6228A (en) 2002-01-15
EE200200039A (en) 2003-04-15
EP1200096A1 (en) 2002-05-02
ES2219366T3 (en) 2004-12-01
HK1046850B (en) 2004-12-31
CA2378390A1 (en) 2001-02-01
MXPA02000834A (en) 2003-07-14
HUP0202055A3 (en) 2009-03-30
KR20020012010A (en) 2002-02-09
JP2003505421A (en) 2003-02-12
BG106358A (en) 2002-08-30
BR0012671A (en) 2002-04-09
SK762002A3 (en) 2002-08-06
FR2796553B1 (en) 2001-09-28
DZ3207A1 (en) 2001-02-01
DK1200096T3 (en) 2004-09-13
HUP0202055A2 (en) 2002-09-28
PT1200096E (en) 2004-10-29
FR2796553A1 (en) 2001-01-26
PL354100A1 (en) 2003-12-29
KR100718211B1 (en) 2007-05-15
CA2378390C (en) 2008-09-23
HK1046850A1 (en) 2003-01-30
WO2001007053A1 (en) 2001-02-01
NO20020252L (en) 2002-01-17
AU6296700A (en) 2001-02-13
OA11993A (en) 2006-04-18

Similar Documents

Publication Publication Date Title
MXPA03011006A (en) 1,4-disubstituted benzo-fused cycloalkyl urea compounds.
DK1200418T3 (en) Nematodicidal trifluorobutene
NO20011842D0 (en) Stable, concentrated insulin preparations for pulmonary delivery
PE20020108A1 (en) STRUCTURES AND COMPOSITIONS THAT INCREASE THE STABILITY OF PEROXIDE ASSETS
MY136141A (en) Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors
BR9808491A (en) Calcilic compounds
IT1302347B1 (en) PROCEDURE FOR THE DIRECT PRODUCTION OF HYDROGEN PEROXIDE.
RS50089B (en) Ziprasidone suspension
EP1226809A4 (en) Skin texture-improving agents
TR200201683T2 (en) Substituted phenyl-piperazine derivatives, their preparation and uses
PT882726E (en) CARBAZOL-CARBOXAMID AS 5-HT1F AGONISTS
AU7903400A (en) Selective inhibitors of the urokinase plasminogene activators
DK1235579T3 (en) Pharmaceuticals containing trimegestone
NO20020252L (en) Thixocortol pivalate suspension, mouthwash based thereon and packages containing the same
BR0012751A (en) Serotonergic benzofurans
TR200001745T2 (en) Ketone peroxide derivatives, their preparation and use
EA200300866A1 (en) SUPERIOR SENSITIVE, NON-ISOTON WATER-SOLUBLE NANOCRYSTALS
TR199701298T1 (en) Tetralins.
PE20001223A1 (en) WHITENING COMPOSITIONS
DE50211951D1 (en) Foamable hair treatment products
DE69803517T2 (en) Stabilized aqueous hydrogen peroxide solution
DK0897714T3 (en) The two-component mouthwash
BR0212114A (en) Supported fluridone methods and compositions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application